Excited to share our prediction model for statin muscle side effects published on @LancetDigitalH, with a risk calculator available in @OxUInnovation software store. We hope this tool could help address concerns and support well-informed decision making about statin treatment.
NEW Research: Predicting the risk of serious muscle disorders in individuals eligible for statin treatment in England: derivation and validation of a clinical prediction model. @TingCai1004@jamessheppard48
Read it here: https://t.co/ge2nuCot1h
Great internship opportunities at Oxford! I am looking for students with enthusiasm for Applied Machine Learning in medical research and Health Data Sciences to join our exciting project DRIVEN (Drug Repurposing and targetIng for dementia preVENtion) 💻💊 https://t.co/HA6cH9JEAQ
This week I successfully passed my DPhil viva! I am so grateful to my supervisors @jamessheppard48, Richard Hobbs, @constantinos989, Jennifer Hirst, and @BrianDNicholson for all their support and guidance, also to my examiners @prof_mant and @oke_jason who recognised my work.
In line with the theme of #ICPE22: advancing pharmacoepidemiology and real-world evidence, our study developed a prediction tool using the advanced competing risk model with routine healthcare records for the risk of the most concerning adverse event of statins.
What can the world learn from China’s response to SARS-CoV-2? This collection of articles sheds light on China’s pandemic experience and draws out lessons for the rest of the world https://t.co/fpPgUZR2ti
Brilliant Julian! It's really important that all the evidence/models/tools we created to support treatment decision making can be properly used in clinical practice. Your work is very valuable!
This 2-minute video highlights GPs' use of quantitative data in decision making during consultations for long-term conditions https://t.co/vRb1k7wBju
@JulianTreadwel1@trishgreenhalgh@OxPrimaryCare
Anticoagulation is critical to reduce stroke risk in people with #AFib, but how can healthcare systems deliver this service most cost-effectively? Our #systematicreview in @TH_Journal, aims to find out: ttp://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1515-9428
DPhil student Ting Cai's first academic paper is out in @bmj_latest today: showing that the balance of benefit to harm of statin treatment is "generally favourable".
@TingCai1004@TheBHF#primarycare#gpnews
BMJ: https://t.co/INovVlWVr1
Summary:⬇️https://t.co/RyDK4SZkzU
Our study published today on the BMJ, showing the benefit-to-harm balance of statins is generally favourable for primary prevention of cardiovascular disease. This should alleviate some concerns from patients and clinians. @bmj_latest#Statin
A new @bmj_latest study suggests benefit-to-harm balance of statins for healthy adults “generally favourable” https://t.co/8JcAgoAoIv @jamessheppard48@TingCai1004